Since terazosin is known to increase PGK1 activity,30,31,44 we hypothesised that the therapeutic effects observed in ALS models may be occurring due to changes in glycolysis and/or respiration. This evidence concerns the gene PGK1 and amyotrophic lateral sclerosis.